Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effectiveness，Safety，Thymic Cancer”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT00990535
What this trial is testing

High Dose Somatostatin Analogues in Neuroendocrine Tumors

Who this might be right for
Respiratory Tract NeoplasmsThymic NeoplasmsPancreatic Neoplasms+2 more
Federico II University 28
Testing effectiveness (Phase 2)Looking for participantsNCT05683886
What this trial is testing

KC1036 in Patients with Advanced Thymic Tumors

Who this might be right for
Thymic Tumors
Beijing Konruns Pharmaceutical Co., Ltd. 30
Not applicableUnknownNCT04975061
What this trial is testing

Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic Cancer

Who this might be right for
Effectiveness，Safety，Thymic Cancer
Shanghai YingLi Pharmaceutical Co. Ltd. 58
Testing effectiveness (Phase 2)Study completedNCT00369889
What this trial is testing

Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Who this might be right for
Thymic CancerThymoma
Indiana University School of Medicine 18
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04710628
What this trial is testing

Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents

Who this might be right for
Metastatic Thymic CarcinomaThymoma Type B3
MedSIR 43
Testing effectiveness (Phase 2)Ended earlyNCT04469725
What this trial is testing

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 95
Early research (Phase 1)Ended earlyNCT04234113
What this trial is testing

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more
SOTIO Biotech AG 115
Testing effectiveness (Phase 2)Study completedNCT04321330
What this trial is testing

Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Who this might be right for
Carcinoma, Thymic
Hoffmann-La Roche 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07343453
What this trial is testing

A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors

Who this might be right for
Thymic Epithelial TumorsAdvanced StageSecond-line Therapy
Sun Yat-sen University 38
Testing effectiveness (Phase 2)Temporarily pausedNCT03704714
What this trial is testing

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaB-Cell Non-Hodgkin LymphomaCD20 Positive+5 more
Northwestern University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06790706
What this trial is testing

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Who this might be right for
Peritoneal MesotheliomaGestational Trophoblastic TumorThymoma and Thymic Carcinoma+3 more
Hospices Civils de Lyon 154
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126